Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Query: "TILT[LastUpdatePostDate]SEARCH[Study]AREA[SponsorSearch]Reata Pharmaceuticals, Inc."
Count: 48
Selected: 0
NCT IDTitle
NCT02255422RTA 408 Capsules in Patients With Mitochondrial Myopathy - MOTOR
NCT04702997A Trial of Bardoxolone Methyl in Patients With CKD at Risk of Rapid Progression (MERLIN)
NCT03918447A Trial of Bardoxolone Methyl in Patients With ADPKD - FALCON
NCT02036970Bardoxolone Methyl Evaluation in Patients With Pulmonary Hypertension (PH) - LARIAT
NCT02259231RTA 408 Capsules in Patients With Melanoma - REVEAL
NCT02657356Bardoxolone Methyl in Patients With Connective Tissue Disease-associated Pulmonary Arterial Hypertension - CATALYST
NCT03068130Extended Access Program to Assess Long-term Safety of Bardoxolone Methyl in Patients With Pulmonary Hypertension RANGER
NCT03019185A Phase 2/3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients With Alport Syndrome - CARDINAL
NCT03749447An Extended Access Program for Bardoxolone Methyl in Patients With CKD (EAGLE)
NCT02255435RTA 408 Capsules in Patients With Friedreich's Ataxia - MOXIe
NCT03593499Expanded Access to Omaveloxolone for Melanoma for Patients Previously Enrolled in 408-C-1401
NCT03902002A Pharmacokinetic Study of Omaveloxolone in Subjects With Hepatic Impairment and Normal Hepatic Function
NCT04008186A Clinical Drug-Drug Interaction (DDI) Study With Omaveloxolone
NCT03931590A Human AME Study for Omaveloxolone
NCT03366337A Phase 2 Trial of the Safety and Efficacy of Bardoxolone Methyl in Patients With Rare Chronic Kidney Diseases - PHOENIX
NCT03664453A Pharmacokinetic Study of Omaveloxolone in Healthy Volunteers
NCT03579030Safety and PK/PD of RTA 1701 in Healthy Adults
NCT03264079Effect of Itraconazole on the Pharmacokinetics of Bardoxolone Methyl in Healthy Adults
NCT02666963A Study of the Safety, Tolerability, and Pharmacokinetics of Single and Multiple Doses of RTA 901 in Healthy Adults
NCT02142959RTA 408 Lotion in Patients at Risk for Radiation Dermatitis - PRIMROSE
NCT02128113RTA 408 Ophthalmic Suspension for the Prevention of Corneal Endothelial Cell Loss Following Cataract Surgery - GUARD
NCT02029729RTA 408 in the Treatment of Advanced Solid Tumors (NSCLC & Melanoma) - DISCOVER
NCT00538343RTA 744 in Breast Cancer Patients With Progression of Previously Irradiated Brain Metastases
NCT00529113Study With Gemcitabine and RTA 402 for Patients With Unresectable Pancreatic Cancer
NCT00527410A Safety Study of RTA 744 in Recurrent, Progressive or Refractory Neoplastic Meningitis
NCT00526812A Safety Study of RTA 744 in Patients With Recurrent High-Grade Gliomas
NCT02065375RTA 408 Ophthalmic Suspension for the Treatment of Ocular Inflammation and Pain Following Ocular Surgery
NCT02029716RTA 408 Lotion in Healthy Volunteers
NCT00529438RTA 402 in Patients With Advanced Solid Tumors or Lymphoid Malignancies
NCT01500798A Pharmacodynamic Study of Measured Glomerular Filtration Rate in Patients With Chronic Kidney Disease and Type 2 Diabetes
NCT00535314Study of Two Dose Levels of RTA 402 in Patients With Advanced Malignant Melanoma
NCT01351675Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
NCT01549769Pharmacokinetic and Pharmacodynamic Study of Bardoxolone Methyl in Patients With Chronic Kidney Disease and Type 2 Diabetes
NCT01689116Multiple-Dose Study of Effect of Bardoxolone Methyl on QT/QTC Interval Volunteers
NCT01563562Single-Dose, Open-Label Pharmacokinetic Study of Bardoxolone Methyl in Subjects With Mild, Moderate, and Severe Hepatic Impairment and Normal Hepatic Function
NCT00664027Phase IIa Trial to Determine the Effects of Bardoxolone Methyl on Renal Function in Patients With Diabetic Nephropathy
NCT01598363An Open-Label Study of the Effect of Bardoxolone Methyl on the Single Dose Pharmacokinetics of Digoxin and Rosuvastatin in Healthy Volunteers
NCT01576887A Double-Blind, Randomized, Placebo-Controlled Safety Study Evaluating the Effects of Residual Renal Function (RFF) in Patients With End-Stage Renal Disease and Type 2 Diabetes Mellitus on Peritoneal Dialysis
NCT01551446Pilot Assessment of the Effects of Bardoxolone Methyl on Renal Perfusion, Systemic Haemodynamics and Cardiac Function in Patients With Chronic Kidney Disease and Type 2 Diabetes
NCT01655186A Double-Blind, Randomized, Placebo-Controlled Study Evaluating the Effects of Bardoxolone Methyl on Body Composition in Patients With Stage 4 Chronic Kidney Disease and Type 2 Diabetes Mellitus
NCT01053936Phase II Pharmacodynamic Trial to Determine the Effects of Bardoxolone Methyl on eGFR in Patients With Type 2 Diabetes and Chronic Kidney Disease
NCT00811889Trial to Determine the Effects of Bardoxolone Methyl on eGFR in Patients With Type 2 Diabetes and Chronic Kidney Disease
NCT01461161A Single-Dose, Open-Label, Randomized, Food Effect and Blinded, Randomized, Dose Proportionality Study in Healthy Volunteers With Bardoxolone Methyl
NCT01503866A Phase I Study to Investigate the Absorption, Metabolism and Excretion in Healthy Male Subjects
NCT00550849Study to Assess the Safety, Tolerability, and Pharmacodynamics of RTA 402 in Patients With Hepatic Dysfunction
NCT04494646BARCONA: A Study of Effects of Bardoxolone Methyl in Participants With SARS-Corona Virus-2 (COVID-19)
NCT00512460RTA 744 Injection in Patients With Leptomeningeal Disease
NCT00508807RTA 402 in Advanced Solid Tumors or Lymphoid Malignancies